---
title: "HitGen: Shareholders plan to reduce their holdings by no more than 5 million shares of the company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251429834.md"
description: "HitGen announced on the evening of August 4th that its shareholder Shenzhen JunTian Investment Enterprise intends to reduce its holdings of the company's shares by a total of 2 million shares through centralized bidding, which accounts for approximately 0.5% of the company's total share capital; Lhasa Economic and Technological Development Zone Huabo Medical Devices Co., Ltd. intends to reduce its holdings of the company's shares by no more than 3 million shares through centralized bidding, which accounts for approximately 0.75% of the company's total share capital"
datetime: "2025-08-04T10:10:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251429834.md)
  - [en](https://longbridge.com/en/news/251429834.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251429834.md)
---

# HitGen: Shareholders plan to reduce their holdings by no more than 5 million shares of the company

HitGen announced on the evening of August 4th that its shareholder Shenzhen JunTian Investment Enterprise intends to reduce its holdings of a total of 2 million shares of the company through centralized bidding, accounting for approximately 0.5% of the company's total share capital; Lhasa Economic and Technological Development Zone Huabo Medical Equipment Co., Ltd. intends to reduce its holdings of no more than 3 million shares of the company through centralized bidding, accounting for approximately 0.75% of the company's total share capital

### Related Stocks

- [688222.CN](https://longbridge.com/en/quote/688222.CN.md)

## Related News & Research

- [Hidden Cost Of Financial Inaction, And How To Break The Cycle - The Decision You Make By Not Deciding](https://longbridge.com/en/news/286786034.md)
- [Grown Up Group Sets June 2026 AGM to Approve Results and Share Mandate](https://longbridge.com/en/news/286990715.md)
- [20:00 ETAccro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases](https://longbridge.com/en/news/286830151.md)
- [Rare bicentennial quarter sells for $19,200 at auction](https://longbridge.com/en/news/286962858.md)
- [Chicago Concerned Citizens Call on City Council to Protect Small Businesses and Pursue Smarter Regulation of Prize and Gift Kiosks](https://longbridge.com/en/news/286834001.md)